MPO与PR3-ANCA化学发光免疫分析的验证、实施与协调
该研究验证并协调了化学发光免疫分析法(QUANTA Flash)检测MPO-和PR3-ANCA的性能,并与两种ELISA方法进行比较。结果显示QUANTA Flash的精密度和线性良好,与ELISA总体一致性为97.5-98.8%(κ 0.861-0.947),对AAV的诊断性能与ELISA相似,且基于区间似然比(LR)有助于结果协调。
要点
- QUANTA Flash检测MPO/PR3-ANCA精密度与线性验证通过,与ELISA一致性高(97.5-98.8%,κ 0.861-0.947)。
- QUANTA Flash对AAV诊断敏感度89.7%、特异度95.9%,与两种ELISA方法统计学相似。
- QUANTA Flash结果区间似然比:0-8 CU为0.08,8-29 CU为1.03,29-121 CU为7.76,121-191 CU为12.4,>191 CU为∞。
核心结论
- QUANTA Flash MPO和PR3检测精密度好、结果一致,对AAV的临床效用与ELISA相当。
- 计算出的似然比与已发表数据一致,支持用似然比协调ANCA结果。
研究设计与样本
- 采用内部ELISA、捕获ELISA和BIO-FLASH分析仪上的QUANTA Flash化学发光法检测血清MPO-和PR3-ANCA。
- 样本来自39例AAV患者、55例非AAV患者和66例结缔组织病患者,评估各方法结果和临床性能。
- 测定了QUANTA Flash的精密度和线性,并计算诊断AAV的似然比。
主要发现
- QUANTA Flash与ELISA的总体一致性为97.5%至98.8%,Cohen's kappa系数为0.861至0.947。
- 诊断AAV的敏感度、特异度和ROC分析:内部ELISA 89.7%、95.0%、0.937;捕获ELISA 92.3%、98.3%、0.939;QUANTA Flash 89.7%、95.9%、0.972,各方法间统计学相似。
- QUANTA Flash结果区间似然比:0-8 CU为0.08,8-29 CU为1.03,29-121 CU为7.76,121-191 CU为12.4,>191 CU为∞。
关键数值与推荐
- QUANTA Flash检测MPO/PR3-ANCA精密度和线性已验证。
- QUANTA Flash与ELISA总体一致性97.5-98.8%,κ 0.861-0.947。
- 诊断AAV的敏感度与特异度:内部ELISA 89.7%与95.0%,捕获ELISA 92.3%与98.3%,QUANTA Flash 89.7%与95.9%。
- ROC曲线下面积:内部ELISA 0.937,捕获ELISA 0.939,QUANTA Flash 0.972。
- 似然比(LR)区间:0-8 CU为0.08,8-29 CU为1.03,29-121 CU为7.76,121-191 CU为12.4,>191 CU为∞。
临床怎么用
- QUANTA Flash可用于MPO-和PR3-ANCA检测,结果与ELISA一致性好。
- 似然比可用于协调不同ANCA检测方法的结果解读。
- 该方法对AAV诊断性能与ELISA相当,可作为临床辅助诊断工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Antineutrophil cytoplasmic antibody (ANCA) testing assists clinicians diagnose ANCA-associated vasculitis (AAV). We aimed to verify and harmonize chemiluminescent immunoassays for the detection of myeloperoxidase (MPO)- and proteinase 3 (PR3)-ANCA. METHODS: An in-house ELISA, a capture ELISA, and a chemiluminescent assay QUANTA Flash on a BIO-FLASH analyzer were used to detect MPO- and PR3-ANCA in sera from 39 patients with AAV, 55 patients with various non-AAV, and 66 patients with connective tissue diseases. The results of the assays were evaluated, and their clinical performance was assessed. The precision and linearity of the QUANTA Flash assays were determined, and likelihood ratios (LRs) for AAV at diagnosis were calculated. RESULTS: The precision and linearity of the QUANTA Flash assays were confirmed. Overall agreement between 97.5 and 98.8 % and Cohen's kappa coefficients between 0.861 and 0.947 were observed for the results of the QUANTA Flash assays and ELISAs. The diagnostic sensitivity, specificity, and ROC analysis of the assays for AAV were statistically similar (in-house ELISA 89.7 %, 95.0 %, and 0.937; capture ELISA 92.3 %, 98.3 %, and 0.939; and QUANTA Flash 89.7 %, 95.9 %, and 0.972). For the QUANTA Flash assay results, the interval-specific LRs for AAV at diagnosis were: 0-8 CU had LR 0.08, 8-29 CU had LR 1.03, 29-121 CU had LR 7.76, 121-191 CU had LR 12.4, and >191 CU had LR ∞. CONCLUSIONS: The QUANTA Flash MPO and PR3 assays provide precise and consistent results and have comparable clinical utility for AAV. The calculated LRs were consistent with published LRs, confirming the utility of LRs for harmonization of ANCA results.
引用
- Ogrič M, Švec T, Poljšak KM, et al. Verification, implementation and harmonization of automated chemiluminescent immunoassays for MPO- and PR3-ANCA detection. Clin Chem Lab Med. 2023. PMID: 37870064. doi:10.1515/cclm-2023-0764
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。